The open-label study of the impact of dapagliflozin to the visceral fat for diabetes patients
Not Applicable
- Conditions
- Type 2 diabetes patients
- Registration Number
- JPRN-UMIN000017974
- Lead Sponsor
- Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Dapagliflozin in use History of hypersensitivity to dapagliflozin containing components Severe ketosis diabetic coma or precoma Severe infection before and after surgery severe trauma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method visceral fat
- Secondary Outcome Measures
Name Time Method clinical indicators abdominal circumference Hypoglycemia Body weight